| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 602910 | 69201 | MEPIVACAINA NORMON 10 MG/ML SOLUCION INYECTABLE EFG | MEPIVACAINA NORMON 10 MG/ML SOLUCION INYECTABLE EFG, 100 ampollas de 10 ml | 10 mg/ml inyectable 10 ml | 1 | 100 | 1 | 100 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69201/69201_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69201/69201_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-08-06 | 1 | 1 | 1 | 2007-08-06 | 2007-08-06 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 602913 | 69203 | MEPIVACAINA NORMON 20 MG/ML SOLUCION INYECTABLE EFG | MEPIVACAINA NORMON 20 MG/ML SOLUCION INYECTABLE EFG, 100 ampollas de 10 ml | 20 mg/ml inyectable 10 ml | 1 | 100 | 1 | 100 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69203/69203_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69203/69203_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-08-06 | 1 | 1 | 1 | 2007-08-06 | 2007-08-06 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 602914 | 69203 | MEPIVACAINA NORMON 20 MG/ML SOLUCION INYECTABLE EFG | MEPIVACAINA NORMON 20 MG/ML SOLUCION INYECTABLE EFG, 100 ampollas de 2 ml | 20 mg/ml inyectable 2 ml | 1 | 100 | 1 | 100 ampollas de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69203/69203_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69203/69203_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-08-06 | 1 | 1 | 1 | 2007-08-06 | 2007-08-06 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 602916 | 69207 | LIDOCAINA NORMON 10 mg/ml SOLUCION INYECTABLE EFG | LIDOCAINA NORMON 10 mg/ml SOLUCION INYECTABLE EFG , 100 ampollas de 10 ml | 10 mg/ml inyectable 10 ml | 1 | 100 | 1 | 100 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69207/69207_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69207/69207_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-08-06 | 1 | 1 | 1 | 2007-08-06 | 2007-08-06 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 602917 | 69208 | LIDOCAINA NORMON 20 mg/ml SOLUCION INYECTABLE EFG | LIDOCAINA NORMON 20 mg/ml SOLUCION INYECTABLE EFG , 100 ampollas de 5 ml | 20 mg/ml inyectable 5 ml | 1 | 100 | 1 | 100 ampollas de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69208/69208_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69208/69208_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-08-06 | 1 | 1 | 1 | 2007-08-17 | 2007-08-06 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 602918 | 69208 | LIDOCAINA NORMON 20 mg/ml SOLUCION INYECTABLE EFG | LIDOCAINA NORMON 20 mg/ml SOLUCION INYECTABLE EFG , 100 ampollas de 10 ml | 20 mg/ml inyectable 10 ml | 1 | 100 | 1 | 100 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69208/69208_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69208/69208_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-08-06 | 1 | 1 | 1 | 2007-08-17 | 2007-08-06 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 602919 | 69209 | LIDOCAINA NORMON 50 mg/ml SOLUCION INYECTABLE EFG | LIDOCAINA NORMON 50 mg/ml SOLUCION INYECTABLE EFG , 100 ampollas de 10 ml | 50 mg/ml inyectable 10 ml | 1 | 100 | 1 | 100 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69209/69209_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69209/69209_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-08-17 | 1 | 1 | 1 | 2007-08-17 | 2007-08-17 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 602949 | 62757 | OMEPRAZOL PENSA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL PENSA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 504 capsulas | 20 mg | 5 | 504 | 43 | 504 capsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62757/62757_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62757/62757_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 1999-10-11 | 1 | 1 | 1 | 1999-10-11 | 2008-04-21 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 602954 | 67315 | RISPERIDONA NORMON 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RISPERIDONA NORMON 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 1 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67315/67315_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67315/67315_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2005-12-01 | 1 | 1 | 1 | 2005-12-01 | 2008-04-25 | 1 | 2011-10-20 | 652855 | View Edit Delete | |||||||||||
| 602957 | 67316 | RISPERIDONA NORMON 3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RISPERIDONA NORMON 3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 3 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67316/67316_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67316/67316_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2005-12-01 | 1 | 1 | 1 | 2005-12-01 | 2008-04-25 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 602958 | 66819 | ENANTYUM 25 mg, GRANULADO PARA SOLUCION ORAL | ENANTYUM 25 mg, GRANULADO PARA SOLUCION ORAL , 500 sobres | 25 mg | 35 | 500 | 64 | 500 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66819/66819_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66819/66819_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1803 | LABORATORIOS MENARINI S.A. | 2005-05-20 | 1 | 1 | 1 | 2005-05-20 | 2008-04-25 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 602986 | 69848 | CANDIFIX 150 mg CAPSULAS DURAS EFG | CANDIFIX 150 mg CAPSULAS DURAS EFG , 100 cápsulas | 150 mg | 5 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69848/69848_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69848/69848_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2008-06-04 | 1 | 1 | 1 | 2008-06-04 | 2008-06-04 | 1 | 2011-11-28 | View Edit Delete | ||||||||||||
| 603003 | 69910 | EPTADONE 5 mg/ml SOLUCION ORAL | EPTADONE 5 mg/ml SOLUCION ORAL, 1 frasco de 1.000 ml | 5 mg/ml | 6 | 1000 | 26 | 1 frasco de 1.000 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69910/69910_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69910/69910_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1585 | LABORATORIOS GEBRO PHARMA S.A. | 2008-06-24 | 1 | 1 | 1 | 2008-06-24 | 2008-06-24 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 603011 | 61109 | CRISTALMINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | CRISTALMINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA, 10 frascos de 500 ml | 10 mg/ml | 91 | 5000 | 26 | 10 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61109/61109_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61109/61109_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 1996-04-01 | 1 | 1 | 1 | 1996-04-01 | 2008-07-09 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 603012 | 61109 | CRISTALMINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | CRISTALMINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA, 30 frascos de 125 ml | 10 mg/ml | 91 | 3750 | 26 | 30 frascos de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61109/61109_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61109/61109_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 1996-04-01 | 1 | 1 | 1 | 1996-04-01 | 2008-07-09 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 603013 | 98069009 | PLAVIX 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PLAVIX 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 300 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98069009/98069009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98069009/98069009_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2008-07-11 | 1 | 1 | 1 | 2008-07-11 | 2008-07-11 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 603029 | 65149 | ZALDIAR 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZALDIAR 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 37,5 mg/325 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65149/65149_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65149/65149_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 2002-12-23 | 1 | 1 | 1 | 2002-12-23 | 2008-07-28 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 603030 | 70000 | NORADRENALINA NORMON 0,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | NORADRENALINA NORMON 0,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 100 ampollas de 10 ml | 0,5 mg/ml inyectable 10 ml | 1 | 100 | 1 | 100 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70000/70000_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70000/70000_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2008-07-31 | 1 | 1 | 1 | 2008-07-31 | 2008-07-31 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 603035 | 64258 | EMULIQUEN LAXANTE 7.173,9 mg/4,5 mg EMULSION ORAL EN SOBRES | EMULIQUEN LAXANTE 7.173,9 mg/4,5 mg EMULSION ORAL EN SOBRES , 200 sobres | 7.173 mg/4,5 mg | 35 | 200 | 64 | 200 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64258/64258_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64258/64258_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2001-09-28 | 1 | 1 | 1 | 2001-09-28 | 2001-09-28 | 1 | 2011-05-27 | View Edit Delete | ||||||||||||
| 603065 | 05330010 | ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA | ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA , 10 tubos dosificadores orales precargados de 1,5 ml | N/A (vacuna) | 44 | 10 | 17 | 10 tubos dosificadores orales precargados de 1,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05330010/05330010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05330010/05330010_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | GLAXOSMITHKLINE S.A. | 2008-09-25 | 1 | 1 | 1 | 2008-09-25 | 2008-09-25 | 1 | 2024-02-20 | View Edit Delete |
Page 8 of 1035, showing 20 records out of 20689 total, starting on record 141, ending on 160